Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope

Vaccine. 2006 Jun 5;24(23):4995-5002. doi: 10.1016/j.vaccine.2006.03.083. Epub 2006 Apr 18.

Abstract

To understand the cross-reactivity of antibodies directed against variable regions of human immunodeficiency virus-1 (HIV-1) envelope (Env), chimeric immunogens were prepared from different clades with modifications in variable regions, and the resulting neutralizing antibody response was evaluated. The V3-specific neutralization activity induced by a clade B immunogen was limited to clade B viruses and was blocked by a clade B V3 peptide, but not by analogous clade A or C V3 peptides. In contrast, the V3 response elicited by a clade C immunogen cross-reacted with sensitive clade B viruses. The V3 region from a clade C virus, when introduced into a clade B sequence, elicited cross-clade activity, which could be reversed by V3 peptides derived from clades A and C. Thus, the anti-V3 antibody response elicited by a clade C immunogen could cross-react with heterologous clade viruses. Additionally, we describe a V1-specific immune response that mediated neutralization limited to the homologous HIV IIIB isolate and may be partially responsible for the commonly observed strain-specific neutralization responses elicited by vaccine immunogens.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • AIDS Vaccines / immunology
  • Animals
  • Antibodies, Viral / immunology*
  • Antibody Specificity*
  • Cell Line
  • Genetic Variation
  • Guinea Pigs
  • HIV Envelope Protein gp120 / immunology*
  • HIV Infections / immunology
  • HIV Infections / prevention & control
  • HIV-1 / classification*
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Immunization
  • Immunoglobulin G
  • Neutralization Tests
  • Peptide Fragments / immunology*
  • Species Specificity

Substances

  • AIDS Vaccines
  • Antibodies, Viral
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Immunoglobulin G
  • Peptide Fragments